TuisCONCORDBIO • NSE
add
Concord Biotech Ltd
Vorige sluiting
₹2 131,65
Dagwisseling
₹2 030,00 - ₹2 190,00
Jaarwisseling
₹997,85 - ₹2 664,00
Markkapitalisasie
214,47Â mjd INR
Gemiddelde volume
442,14Â k
P/V-verhouding
68,49
Dividend-opbrengs
0,43%
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,16Â mjd | 10,77% |
Bedryfskoste | 994,02Â m | 4,28% |
Netto inkomste | 595,93Â m | 9,36% |
Netto winsgrens | 27,61 | -1,29% |
Wins per aandeel | 5,70 | — |
EBITDA | 810,63Â m | 12,11% |
Effektiewe belastingkoers | 25,06% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,82Â mjd | 64,71% |
Totale bates | — | — |
Totale aanspreeklikheid | — | — |
Totale ekwiteit | 15,27 mjd | — |
Uitstaande aandele | 104,55 m | — |
Prys om te bespreek | 14,61 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 11,08% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 595,93Â m | 9,36% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Gestig
2000
Webwerf
Werknemers
1Â 377
